James Moran - 25 Sep 2024 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role
Director
Signature
/s/ James P Moran
Issuer symbol
IGC
Transactions as of
25 Sep 2024
Net transactions value
+$200,000
Form type
4
Filing time
27 Sep 2024, 16:05:18 UTC
Previous filing
15 Mar 2024
Next filing
15 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGC Common Stock Purchase $200,000 +588,235 +166% $0.3400 942,402 25 Sep 2024 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of IGC Pharma, Inc. ("IGC") common stock purchased directly from IGC by Moran Global Strategies, Inc ("MGS"), a Virginia corporation that is owned by James Moran a director of IGC, subject to the terms and conditions set forth in the 2024 Share Purchase Agreement filed with the SEC on Form 8-K on September 25, 2024. The Reporting Person hereby disclaims beneficial ownership of all securities, except to the extent of any indirect pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.